Literature DB >> 8408047

Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper.

T Nomura1, N Sakai, A Sarai, T Sudo, C Kanei-Ishii, R G Ramsay, D Favier, T J Gonda, S Ishii.   

Abstract

The trans-activating and transforming capacities of the c-myb proto-oncogene product (c-Myb) are negatively regulated through a leucine zipper structure in its negative regulatory domain. We show here tht in cotransfection assays, maximal Myb-induced trans-activation occurs with relatively low amounts of wild-type c-Myb, while higher levels of c-Myb result in reduced Myb-induced trans-activation. By contrast, this apparent negative autoregulation is not observed with a c-Myb mutant containing an impaired leucine zipper. Data presented here suggest that this negative autoregulation of trans-activation by wild-type c-Myb is a consequence of homodimer formation by c-Myb through its leucine zipper and of the inability of c-Myb dimers to bind DNA. These findings point to a novel mechanism of regulation of a transcription factor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408047

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.

Authors:  A L Zaiman; J Lenz
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  FAETL motif required for leukemic transformation by v-Myb.

Authors:  S L Fu; J S Lipsick
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Functional analysis of carboxy-terminal deletion mutants of c-Myb.

Authors:  D M Wang; J W Dubendorff; C H Woo; J S Lipsick
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

Authors:  A Biroccio; B Benassi; I D'Agnano; C D'Angelo; S Buglioni; M Mottolese; A Ricciotti; G Citro; M Cosimelli; R G Ramsay; B Calabretta; G Zupi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  Molecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly nucleolar protein which may play a role in transactivation by Myb.

Authors:  F J Tavner; R Simpson; S Tashiro; D Favier; N A Jenkins; D J Gilbert; N G Copeland; E M Macmillan; J Lutwyche; R A Keough; S Ishii; T J Gonda
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

6.  Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb.

Authors:  Atul Kumar; Stacey J Baker; Clement M Lee; E Premkumar Reddy
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

7.  The carboxyterminus of human c-myb protein stimulates activated transcription in trans.

Authors:  G Vorbrueggen; F Kalkbrenner; S Guehmann; K Moelling
Journal:  Nucleic Acids Res       Date:  1994-07-11       Impact factor: 16.971

Review 8.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

9.  Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells.

Authors:  G Manzotti; S A Mariani; F Corradini; R Bussolari; V Cesi; J Vergalli; G Ferrari-Amorotti; V Fragliasso; A R Soliera; S Cattelani; G Raschellà; T L Holyoake; B Calabretta
Journal:  Blood Cancer J       Date:  2012-05-11       Impact factor: 11.037

10.  Glucocorticoid-induced leucine zipper (GILZ)/NF-kappaB interaction: role of GILZ homo-dimerization and C-terminal domain.

Authors:  Barbara Di Marco; Michela Massetti; Stefano Bruscoli; Antonio Macchiarulo; Rosa Di Virgilio; Enrico Velardi; Valerio Donato; Graziella Migliorati; Carlo Riccardi
Journal:  Nucleic Acids Res       Date:  2006-12-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.